MRK Insider Trading
Insider Ownership Percentage: 0.09%
Insider Buying (Last 12 Months): $250,012.25
Insider Selling (Last 12 Months): $209,562.36
Merck & Co., Inc. Insider Trading History Chart
This chart shows the insider buying and selling history at Merck & Co., Inc. by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Merck & Co., Inc. Share Price & Price History
Current Price: $83.20
Price Change: ▲ Price Increase of +0.46 (0.56%)
As of 04/28/2025 04:59 PM ET
Merck & Co., Inc. Insider Trading History
Merck & Co., Inc. Institutional Trading History
Data available starting January 2016
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Read More on Merck & Co., Inc.
Today's Range
Now: $83.20
52 Week Range
Now: $83.20
Volume
14,235,803 shs
Average Volume
11,870,150 shs
Market Capitalization
$209.81 billion
P/E Ratio
12.36
Dividend Yield
3.92%
Beta
0.4
Who are the company insiders with the largest holdings of Merck & Co., Inc.?
Who are the major institutional investors of Merck & Co., Inc.?
Which institutional investors are selling Merck & Co., Inc. stock?
During the previous quarter, MRK stock was sold by these institutional investors:
- Handelsbanken Fonder AB
- Principal Financial Group Inc.
- Retirement Systems of Alabama
- Compagnie Lombard Odier SCmA
- IMC Chicago LLC
- Allspring Global Investments Holdings LLC
- MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH
- KBC Group NV
Which institutional investors are buying Merck & Co., Inc. stock?
During the last quarter, MRK stock was acquired by institutional investors including:
- GAMMA Investing LLC
- Sarasin & Partners LLP
- Mirae Asset Global Investments Co. Ltd.
- AEGON ASSET MANAGEMENT UK Plc
- Compass Capital Management Inc.
- CX Institutional
- Foster Victor Wealth Advisors LLC
- Wealth Enhancement Advisory Services LLC